Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr766 Inhibitors

Olr766 inhibitors represent a specialized class of chemical compounds characterized by their ability to selectively bind to and inhibit the function of the Olr766 protein. Olr766, a member of the olfactory receptor family, is a G-protein-coupled receptor (GPCR) involved in olfactory signaling pathways. The inhibition of Olr766 disrupts its normal signaling processes, which can be pivotal for studying the mechanistic pathways of olfaction and the molecular basis of smell perception. Olr766 inhibitors typically exhibit high specificity and affinity for the Olr766 receptor, ensuring that off-target effects are minimized. These inhibitors are designed through intricate processes of molecular modeling and structure-activity relationship (SAR) studies, which help in identifying the most effective chemical moieties that can interact with the active sites of Olr766.

The chemical structure of Olr766 inhibitors often includes key functional groups that facilitate binding to the receptor's active site, such as aromatic rings, nitrogen-containing heterocycles, and various side chains that enhance lipophilicity and receptor affinity. These structural components are meticulously engineered to optimize the inhibitory potency and stability of the compounds. Additionally, the synthesis of Olr766 inhibitors involves advanced organic synthesis techniques, including multi-step reactions and purification processes to achieve high purity and yield. Researchers employ various analytical methods, such as NMR spectroscopy, mass spectrometry, and X-ray crystallography, to confirm the structure and binding efficacy of these inhibitors. The study of Olr766 inhibitors not only contributes to the understanding of olfactory receptors' structural and functional dynamics but also provides valuable insights into the broader family of GPCRs, which are crucial in numerous biological processes beyond olfaction.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Src family kinase inhibitor, potentially affecting proteins in cell growth and survival pathways.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

mTOR inhibitor, potentially disrupting proteins in the PI3K/AKT/mTOR signaling pathway.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

EGFR inhibitor, potentially affecting proteins in the epidermal growth factor receptor pathway.

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

Dual EGFR and HER2 inhibitor, potentially affecting proteins in related signaling pathways.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

EGFR inhibitor, potentially targeting proteins in the epidermal growth factor receptor pathway.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

CDK4/6 inhibitor, potentially affecting cell cycle regulation proteins.

Ribociclib

1211441-98-3sc-507367
10 mg
$450.00
(0)

CDK4/6 inhibitor, potentially impacting proteins involved in cell cycle regulation.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Multi-kinase inhibitor, potentially affecting proteins in VEGF and PDGF signaling pathways.

Temozolomide

85622-93-1sc-203292
sc-203292A
25 mg
100 mg
$89.00
$250.00
32
(1)

Alkylating agent, potentially affecting DNA repair proteins.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Immunomodulatory drug, potentially affecting proteins involved in immune response and angiogenesis.